Rapid Dose Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is March - February.

Millions USD. Fiscal year is Mar - Feb.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2020
Period Ending	Apr '25 Apr 7, 2025	Feb '25 Feb 28, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022	Feb '21 Feb 28, 2021	2018 - 2020
Market Capitalization	19	15	15	7	21	13	Upgrade
Market Cap Growth	0.45%	0.45%	121.72%	-67.18%	56.53%	-32.70%	Upgrade
Enterprise Value	21	17	17	8	22	15	Upgrade
Last Close Price	0.14	0.18	0.02	0.00	0.20	0.19	Upgrade
PS Ratio	12.95	10.56	20.20	12.98	15.10	22.43	Upgrade
PB Ratio	-5.19	-4.23	-6.53	-3.49	105.16	-15.54	Upgrade
P/TBV Ratio	-	-	-	-	105.16	-	Upgrade
EV/Sales Ratio	13.58	11.79	23.00	15.75	15.81	24.39	Upgrade
Debt / Equity Ratio	-0.50	-0.50	-0.78	-0.79	5.70	-2.01	Upgrade
Asset Turnover	1.19	1.19	0.49	0.27	0.51	0.19	Upgrade
Inventory Turnover	4.25	4.25	2.79	1.67	1.26	0.43	Upgrade
Quick Ratio	0.05	0.05	0.13	0.04	0.09	0.08	Upgrade
Current Ratio	0.10	0.10	0.23	0.09	0.25	0.19	Upgrade
Return on Assets (ROA)	-148.14%	-148.14%	-93.37%	-83.34%	-77.93%	-25.16%	Upgrade
Return on Capital (ROIC)	-	-	-	-389.55%	-193.25%	-88.74%	Upgrade
Earnings Yield	-20.02%	-24.54%	-20.89%	-40.87%	-32.08%	-10.66%	Upgrade
FCF Yield	-4.27%	-5.23%	-11.13%	-9.27%	-11.49%	-9.64%	Upgrade
Buyback Yield / Dilution	-18.68%	-18.68%	-1.50%	-3.19%	-28.83%	-2.23%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.